Hotpennystocknews.com is devoted to fetch you the most exclusive stocks in the market today. Apart from scanning the markets for the most underrated stocks. We propel those victors directly to your email inbox first ahead of the rest of the marketplace gets a prospect.
Los Angeles, CA -- (SBWIRE) -- 01/31/2014 -- Hotpennystocknews.com issues special report on - All grade mining inc. (HYII), Roche (OTCMKTS:RHHBY)
The mission of All grade mining inc. (HYII) is to acquire mining concessions in all phases, all sizes and all minerals. Their current energies are focused in south America, primarily Chile.Through established professionals our goal is bring projects from exploration to exploitation.
All Grade Mining, Inc. currently owns an iron ore concession in central Chile, III Region. The Salitrosa Property is currently undergoing its environmental impact declaration and feasibility studies allowing us to process in excess of 50 thousand tons of iron per month.
All Grade Mining, inc. is also in the process of acquiring a small scale copper concession in the same region. As a smaller scale project, the start up time will be shorter and therefore production can begin faster and create cash flow to operate the Company.
With the combination of small and large scale projects, All Grade will have the ability to create cash flow from the small concessions and the ability to invest time and money into the exploration of larger scale projects.
They believe that this combination will allow for the success and growth of All Grade into a significant supplier of minerals throughout the world.
HYII is +0.0001 - +50.00% from the previous close of $0.0002. It traded between $0.0002 - 0.0004 with total traded volume of 405083584 shares. At Current Market Price, HYII is in distance of -97.24% from its 50-day Moving Average price of $0.0109 and -98.99% from its 200-day Moving Average price of $0.0297.
Should Investors Buy HYII Now? Free Sign Up Here For HYII Analyst Report.
Headquartered in Basel, Switzerland, Roche (OTCMKTS:RHHBY) is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company, with truly differentiated medicines in oncology, infectious diseases, inflammation, metabolism and neuroscience. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2012 Roche had over 82,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 45.5 billion Swiss francs. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.
RHHBY is -0.475 - -0.69% from the previous close of $69.275. It traded between $68.05 - 68.95 with total traded volume of 462557 shares. At Current Market Price, RHHBY is in distance of +0.04% from its 50-day Moving Average price of $68.7718 and +3.18% from its 200-day Moving Average price of $66.679.
How Should Investors Trade RHHBY After The Recent Volatile Moves? Find Out Here.
Neither Hotpennystocknews.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor or broker dealer in any jurisdiction whatsoever and none of the information provided by Hotpennystocknews.com, owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or an investment recommendation.Hotpennystocknews.com makes no recommendation that the securities of the companies profiled should be purchased, sold or held by individuals or entities that learn of the profiled companies through Hotpennystocknews.com. Investing in securities is speculative and carries a high degree of risk and no investment should be made unless you can afford to lose your entire investment. It is possible that an investor's entire investment may be lost or impaired due to the speculative nature of the companies profiled. Please consult a broker before purchasing or selling any securities viewed on or mentioned here in.
Read Full disclaimer at:http://www.hotpennystocknews.com/disclaimer.php
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)